Hematologic Toxicity | List of Frontiers open access articles

Case Report

Published on 16 Jun 2022

Case Report: ITP Treatment After CAR-T Cell Therapy in Patients With Multiple Myeloma

in Cancer Immunity and Immunotherapy

Mengyi Du
Linlin Huang
Haiming Kou
Chenggong Li
Yu Hu
Heng Mei

Frontiers in Immunology

doi 10.3389/fimmu.2022.898341

8,693 views
7 citations

Original Research

Published on 12 Aug 2020

Sarcopenia Is Associated With Hematologic Toxicity During Chemoradiotherapy in Patients With Anal Carcinoma

in Radiation Oncology

Daniel Martin
Jens von der Grün
Claus Rödel
Emmanouil Fokas

Frontiers in Oncology

doi 10.3389/fonc.2020.01576

3,690 views
11 citations

Original Research

Published on 04 Mar 2025

Radiation hematologic toxicity prediction in rectal cancer: a comparative radiomics-based study on CT image and dose map

in Radiation Oncology

Yingpeng Liu
Liping Guo
Yi Wang
Qingtao Xu
Jingfeng Zhang
Xianyun Meng

Frontiers in Oncology

doi 10.3389/fonc.2025.1516855

1,652 views

Original Research

Published on 08 Aug 2025

Combined clinical and MRI-based radiomics model for predicting acute hematologic toxicity in gynecologic cancer radiotherapy

in Radiation Oncology

Lumeng Luo
Jiahao Wang
Hongling Xie
Bingxin Chen
Hui Wang
Qiu Tang

Frontiers in Oncology

doi 10.3389/fonc.2025.1644053

1,771 views
1 citation

Case Report

Published on 09 Oct 2025

Case Report: Severe neutropenia induced by avelumab in a patient with Merkel cell carcinoma

in Cancer Immunity and Immunotherapy

Eri Ohta
Kayo Yamamoto
Hitomi Fujimura
Natsuko Saito-Sasaki
Etsuko Okada
Yu Sawada

Frontiers in Immunology

doi 10.3389/fimmu.2025.1672282

1,316 views
1 citation

Original Research

Published on 17 Dec 2020

Which Bone Marrow Sparing Strategy and Radiotherapy Technology Is Most Beneficial in Bone Marrow-Sparing Intensity Modulated Radiation Therapy for Patients With Cervical Cancer?

in Radiation Oncology

De-Yang Yu
Yan-Ling Bai
Yue Feng
Le Wang
Wei-Kang Yun
Xin Li
Jia-Yu Song
Shan-Shan Yang
Yun-Yan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2020.554241

7,421 views
18 citations

Original Research

Published on 09 Mar 2022

Vincristine, Irinotecan, and Temozolomide in Patients With Relapsed/Refractory Neuroblastoma

in Pediatric Oncology

Jia Zhu
Juan Wang
Feifei Sun
Zijun Zhen
Tingting Chen
Suying Lu
Junting Huang
Yizhuo Zhang
Xiaofei Sun

Frontiers in Oncology

doi 10.3389/fonc.2022.804310

9,220 views
13 citations

Case Report

Published on 17 Nov 2025

Spatially fractionated radiotherapy combined with CapeOX and bevacizumab for postoperative pulmonary metastasis from urachal carcinoma: a case report

in Radiation Oncology

Jian Fang
Aixin Wang
Quan Yao
Xinyi Liu
Weiyi Zhou
Jinyi Lang

Frontiers in Oncology

doi 10.3389/fonc.2025.1688215

1,332 views
1 citation

Original Research

Published on 10 Jan 2024

Association between genetic variants of membrane transporters and the risk of high-grade hematologic adverse events in a cohort of Mexican children with B-cell acute lymphoblastic leukemia

in Cancer Epidemiology and Prevention

Deyanira Escalante-Bautista
Doris Cerecedo
Elva Jiménez-Hernández
Carolina González-Torres
Javier Gaytán-Cervantes
Juan Carlos Núñez-Enríquez
Omar Alejandro Sepúlveda-Robles
Marlon De Ita
Silvia Jiménez-Morales
José Manuel Sánchez-López

Frontiers in Oncology

doi 10.3389/fonc.2023.1276352

4,774 views
2 citations

Original Research

Published on 30 Jun 2022

Redefine the Role of Proton Beam Therapy for the Locally-Advanced Non-Small Cell Lung Cancer Assisting the Reduction of Acute Hematologic Toxicity

in Cancer Imaging and Image-directed Interventions

Xi Cao
Peilin Liu
Xian-shu Gao
Shiyu Shang
Jiayu Liu
Zishen Wang
Mengmeng Su
Xuanfeng Ding

Frontiers in Oncology

doi 10.3389/fonc.2022.812031

3,088 views
1 citation

Original Research

Published on 21 Jul 2020

Comparison of Hematologic Toxicity and Bone Marrow Compensatory Response in Head and Neck vs. Cervical Cancer Patients Undergoing Chemoradiotherapy

in Radiation Oncology

Lucas K. Vitzthum
Elena S. Heide
Helen Park
Casey W. Williamson
Paige Sheridan
Minh-Phuong Huynh-Le
Igor Sirak
Lichun Wei
Rafal Tarnawski
Umesh Mahantshetty

Frontiers in Oncology

doi 10.3389/fonc.2020.01179

7,059 views
21 citations

Original Research

Published on 14 Mar 2023

Low-dose administration of prednisone has a good effect on the treatment of prolonged hematologic toxicity post-CD19 CAR-T cell therapy

in Cancer Immunity and Immunotherapy

Jiaxi Wang
Meng Zhang
Hairong Lyu
Ruiting Guo
Xia Xiao
Xue Bai
Yedi Pu
Juanxia Meng
Qing Li
Ting Yuan

Frontiers in Immunology

doi 10.3389/fimmu.2023.1139559

6,039 views
9 citations

Original Research

Published on 14 May 2019

CYP2J2∗7 Genotype Predicts Risk of Chemotherapy-Induced Hematologic Toxicity and Reduced Relative Dose Intensity in Ethiopian Breast Cancer Patients

in Pharmacogenetics and Pharmacogenomics

Jemal Hussien Ahmed
Eyasu Makonnen
Getnet Yimer
Daniel Seifu
Abebe Bekele
Mathewos Assefa
Abraham Aseffa
Rawleigh Howe
Alan Fotoohi
Moustapha Hassan

Frontiers in Pharmacology

doi 10.3389/fphar.2019.00481

4,799 views
16 citations

Original Research

Published on 22 Apr 2021

Effect of Pelvic Bone Marrow Sparing Intensity Modulated Radiation Therapy on Acute Hematologic Toxicity in Rectal Cancer Patients Undergoing Chemo-Radiotherapy

in Radiation Oncology

Wei Huang
Jun Dang
Ying Li
Hai-xia Cui
Wen-li Lu
Qing-feng Jiang

Frontiers in Oncology

doi 10.3389/fonc.2021.646211

5,400 views
23 citations

Original Research

Published on 09 Sep 2022

Development of a nomogram for predicting grade 2 or higher acute hematologic toxicity of cervical cancer after the pelvic bone marrow sparing radiotherapy

in Digital Public Health

Xiangdi Meng
Nan Wang
Meng Yu
Dechen Kong
Zhengtao Zhang
Xiaolong Chang
Yinghua Guo
Yang Li

Frontiers in Public Health

doi 10.3389/fpubh.2022.993443

3,359 views
9 citations

Original Research

Published on 21 May 2024

Acute hematologic toxicity prediction using dosimetric and radiomics features in patients with cervical cancer: does the treatment regimen matter?

in Radiation Oncology

Haizhen Yue
Xiaofan Li
Jing You
Pujie Feng
Yi Du
Ruoxi Wang
Hao Wu
Jinsheng Cheng
Kuke Ding
Bin Jing

Frontiers in Oncology

doi 10.3389/fonc.2024.1365897

2,828 views
6 citations

Articles

Case Report: ITP Treatment After CAR-T Cell Therapy in Patients With Multiple Myeloma

Sarcopenia Is Associated With Hematologic Toxicity During Chemoradiotherapy in Patients With Anal Carcinoma

Radiation hematologic toxicity prediction in rectal cancer: a comparative radiomics-based study on CT image and dose map

Combined clinical and MRI-based radiomics model for predicting acute hematologic toxicity in gynecologic cancer radiotherapy

Case Report: Severe neutropenia induced by avelumab in a patient with Merkel cell carcinoma

Which Bone Marrow Sparing Strategy and Radiotherapy Technology Is Most Beneficial in Bone Marrow-Sparing Intensity Modulated Radiation Therapy for Patients With Cervical Cancer?

Vincristine, Irinotecan, and Temozolomide in Patients With Relapsed/Refractory Neuroblastoma

Spatially fractionated radiotherapy combined with CapeOX and bevacizumab for postoperative pulmonary metastasis from urachal carcinoma: a case report

Association between genetic variants of membrane transporters and the risk of high-grade hematologic adverse events in a cohort of Mexican children with B-cell acute lymphoblastic leukemia

Redefine the Role of Proton Beam Therapy for the Locally-Advanced Non-Small Cell Lung Cancer Assisting the Reduction of Acute Hematologic Toxicity

Comparison of Hematologic Toxicity and Bone Marrow Compensatory Response in Head and Neck vs. Cervical Cancer Patients Undergoing Chemoradiotherapy

Low-dose administration of prednisone has a good effect on the treatment of prolonged hematologic toxicity post-CD19 CAR-T cell therapy

CYP2J2∗7 Genotype Predicts Risk of Chemotherapy-Induced Hematologic Toxicity and Reduced Relative Dose Intensity in Ethiopian Breast Cancer Patients

Effect of Pelvic Bone Marrow Sparing Intensity Modulated Radiation Therapy on Acute Hematologic Toxicity in Rectal Cancer Patients Undergoing Chemo-Radiotherapy

Development of a nomogram for predicting grade 2 or higher acute hematologic toxicity of cervical cancer after the pelvic bone marrow sparing radiotherapy

Acute hematologic toxicity prediction using dosimetric and radiomics features in patients with cervical cancer: does the treatment regimen matter?